private digital health companies weight loss glp-1 Patient Behavior: How Does Price Sensitivity and Adherence Shape the Market Nationwide GLP-1 Medical Weight Loss

Semaglutide, for example, has structural modifications that make it resistant to DPP-4 degradation, allowing it to remain active in the body for about a week

They are potent stimulators of postprandial insulin secretion under hyperglycemic conditions and contribute to approximately 70% of the physiological postprandial insulin secretion

To create viable therapeutics, researchers had to engineer GLP-1 analogs that resist enzymatic breakdown and persist long enough to exert physiological effects

This week, I unpack whats going on in the brain on these drugs, whether or not this hyped phenomenon of motivation loss is real and what we still dont know

Although TRIUMPH-1 results are promising, Eli Lilly has not yet submitted retatrutide for FDA review